They’re on a rampage…

Aggressive "Desk Clearing" FDA approvals have been fueling some of the biggest gains of 2021… New studies conducted by researchers from Harvard University and MIT have concluded: "The U.S. Food and Drug Administration is approving drugs faster than ever." The report notes…   "Approval spikes occur at the end of each calendar month" and before the "end of the year in a kind of 'desk-clearing' activity." Tune in Monday, November 1st to see exactly why one trader believes the next 61 days will be monumental for specific biotech stocks. Starting with one single ticker that will be announced COMPLETELY FREE during his Live Emergency Briefing. The last time he made a call like this, traders had the ability to nearly triple their money over a single weekend…* When you attend Monday's Live Emergency Briefing, you'll discover the exact steps this biotech trader is taking to trade the FDA's latest decision… Plus everyone who attends will leave with the single ticker he's targeting! All the best, WealthPress *Disclaimer: The profits and performance shown are not typical, we make no future earnings claims, and you may lose money. Disclaimer & Disclosures The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information. WealthPress

 

                                                           

This email was sent to penunggangbadai.moneyblog@blogger.com by WealthPress LLC 7751 Belfort Parkway | Suite 120 | Jacksonville | FL | 32556 Forward to a friend | Unsubscribe From All WealthPress Emails

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: